Internal Bleeding After Taking Xarelto?
If you or a loved one took Xarelto and subsequently suffered serious conditions such as hemorrhaging, internal bleeding, or stroke, you may wish to explore your legal options. The attorneys at 1-800-LAW-FIRM will fight for the justice and financial compensation you deserve.
Xarelto (rivaroxaban) is an anticoagulant (blood thinner) that is prescribed to prevent the formation of blood clots. It was approved by the U.S. Food and Drug Administration (FDA) in 2011 and is manufactured by Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. Xarelto is used to prevent or treat a type of blood clot called deep vein thrombosis (DVT), which can lead to blood clots in the lungs (pulmonary embolism). This medication is also used in people with atrial fibrillation (a heart rhythm disorder) to lower the risk of stroke caused by a blood clot.
The manufacturers of Xarelto are facing lawsuits stating that Xarelto is unsafe and defective. The plaintiffs claim that, unlike traditional anticoagulants (i.e. Warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Because of this, the lawsuits claim, doctors have no effective means of stopping Xarelto patients from bleeding in the event of an emergency. Plaintiffs in the lawsuits allege serious and fatal injuries, including cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.
Because the manufacturers of Xarelto did not properly warn consumers of the potential risks associated with Xarelto, users of the drug (or their loved ones) may be eligible to demand compensation by filing a Xarelto lawsuit. If you or a loved one developed internal bleeding or passed away while taking Xarelto, you may be entitled to compensation.
Cases, Settlements and Verdicts
The first case against Bayer Corp. was filed in the in the Philadelphia County Court of Common Pleas by Kentucky resident Virginia Stuntebeck in February 2014. She suffered from gastrointestinal bleeding which landed her into the hospital in 2013. She claims that Bayer and Johnson and Johnson were negligent in introducing the drug to the market and also questioned the warning label on the drug.
Xarelto Key Points
- Approved by the FDA on November 4th, 2011 to reduce the risk of stroke in people who have abnormal heart rhythm (non-valvular atrial fibrillation)
- Around 130,000 Xarelto prescriptions were written for Xarelto in the U.S.
- On February 2014, the FDA rejected the wider use of Xarelto for preventing new heart attacks and strokes
- In June 2014, a study from the Institute for Safe Medicine Practices reported that bleeding incidents and adverse events related to Xarelto prescriptions are on the rise
Conditions Caused by Xarelto
- Intracranial hemorrhages
- Epidural hematoma
- Gastrointestinal hemorrhages
- Retinal hemorrhages
- Adrenal bleeding
Understand Your Legal Options
If you or a loved one experienced serious complications while taking Xarelto, you may be entitled to compensation. Call 1-800-529-3476 for a free and confidential consultation, or complete the form on the sidebar to be contacted by a member of our team.